Literature DB >> 19608826

The effect of intravenous alanyl-glutamine supplementation on plasma glutathione levels in intensive care unit trauma patients receiving enteral nutrition: the results of a randomized controlled trial.

Ahmet Eroglu1.   

Abstract

BACKGROUND: We sought to investigate the effect of IV alanyl-glutamine supplementation on plasma glutathione levels in severely traumatized patients receiving enteral nutrition.
METHODS: Forty adult patients with severe trauma according to the Injury Severity Score >20 were enrolled in this randomized, controlled study. The patients were assigned to two groups: Group G received 0.5 g x kg(-1) x d(-1) of alanyl-glutamine dipeptide supplementation IV, and Group C received a control solution without alanyl-glutamine for 7 days. Blood samples were taken for analysis of glutathione before the initiation of supplementation and on the 3rd, 7th, and 10th days of feeding.
RESULTS: Total plasma glutathione levels significantly increased in Group G when compared with Group C on Days 7 and 10 (1.34 +/- 0.20 microM vs 1.13 +/- 0.14 microM, and 1.38 +/- 0.19 microM vs 1.12 +/- 0.16 microM) (P < 0.001).
CONCLUSIONS: This study demonstrates that IV alanyl-glutamine supplementation for 7 days increases total plasma glutathione levels in critically ill trauma patients receiving standard enteral nutrition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19608826     DOI: 10.1213/ane.0b013e3181a83178

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

1.  A randomized trial of intravenous glutamine supplementation in trauma ICU patients.

Authors:  Jon Pérez-Bárcena; Pedro Marsé; Arturo Zabalegui-Pérez; Esther Corral; Rubén Herrán-Monge; María Gero-Escapa; Mercedes Cervera; Juan Antonio Llompart-Pou; Ignacio Ayestarán; Joan Maria Raurich; Antonio Oliver; Antonio Buño; Abelardo García de Lorenzo; Guiem Frontera
Journal:  Intensive Care Med       Date:  2014-02-21       Impact factor: 17.440

Review 2.  Glutamine randomized studies in early life: the unsolved riddle of experimental and clinical studies.

Authors:  Efrossini Briassouli; George Briassoulis
Journal:  Clin Dev Immunol       Date:  2012-09-18

3.  Effect of intravenous GLutamine supplementation IN Trauma patients receiving enteral nutrition study protocol (GLINT Study): a prospective, blinded, randomised, placebo-controlled clinical trial.

Authors:  Ruqaiya M Al Balushi; Jennifer D Paratz; Jeremy Cohen; Merrilyn Banks; Joel Dulhunty; Jason A Roberts; Jeffrey Lipman
Journal:  BMJ Open       Date:  2011-11-14       Impact factor: 2.692

Review 4.  Exogenous Glutamine in Respiratory Diseases: Myth or Reality?

Authors:  Gisele P Oliveira; Marcelo Gama de Abreu; Paolo Pelosi; Patricia R M Rocco
Journal:  Nutrients       Date:  2016-02-04       Impact factor: 5.717

5.  Glutamine Supplementation in Intensive Care Patients: A Meta-Analysis of Randomized Clinical Trials.

Authors:  Massimo Oldani; Marta Sandini; Luca Nespoli; Sara Coppola; Davide Paolo Bernasconi; Luca Gianotti
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

Review 6.  Parenteral glutamine supplementation in critical illness: a systematic review.

Authors:  Paul E Wischmeyer; Rupinder Dhaliwal; Michele McCall; Thomas R Ziegler; Daren K Heyland
Journal:  Crit Care       Date:  2014-04-18       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.